Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Low Molecular Heparin Market, by Region, 2019-2029 (USD Billion)
1.2.2. Low Molecular Heparin Market, by Product, 2019-2029 (USD Billion)
1.2.3. Low Molecular Heparin Market, by Application, 2019-2029 (USD Billion)
1.2.4. Low Molecular Heparin Market, by End User, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Low Molecular Heparin Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Low Molecular Heparin Market Dynamics
3.1. Low Molecular Heparin Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing incidence of blood disorders globally
3.1.1.2. Introduction of LMWH anticoagulation
3.1.2. Market Challenges
3.1.2.1. Adverse effects of low molecular weight heparin
3.1.3. Market Opportunities
3.1.3.1. Increasing advantages of low molecular weight heparin over unfractionated heparin
3.1.3.2. Rising growth and development activities by market players
Chapter 4. Global Low Molecular Heparin Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Low Molecular Heparin Market, by Product
6.1. Market Snapshot
6.2. Global Low Molecular Heparin Market by Product, Performance - Potential Analysis
6.3. Global Low Molecular Heparin Market Estimates & Forecasts by Product 2019-2029 (USD Billion)
6.4. Low Molecular Heparin Market, Sub-Segment Analysis
6.4.1. Enoxaparin
6.4.2. Dalteparin
6.4.3. Tinzaparin
6.4.4. Fondaparinux
6.4.5. Others
Chapter 7. Global Low Molecular Heparin Market, by Application
7.1. Market Snapshot
7.2. Global Low Molecular Heparin Market by Application, Performance - Potential Analysis
7.3. Global Low Molecular Heparin Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
7.4. Low Molecular Heparin Market, Sub-Segment Analysis
7.4.1. Deep Vein Thrombosis
7.4.2. Acute Coronary Syndrome (ACS)
7.4.3. Pulmonary Embolism
7.4.4. Other Applications
Chapter 8. Global Low Molecular Heparin Market, by End-User
8.1. Market Snapshot
8.2. Global Low Molecular Heparin Market by End-User, Performance - Potential Analysis
8.3. Global Low Molecular Heparin Market Estimates & Forecasts by End-User 2019-2029 (USD Billion)
8.4. Low Molecular Heparin Market, Sub-Segment Analysis
8.4.1. Hospitals and Clinics
8.4.2. Ambulatory Surgical Centres
8.4.3. Other End Users
Chapter 9. Global Low Molecular Heparin Market, Regional Analysis
9.1. Low Molecular Heparin Market, Regional Market Snapshot
9.2. North America Low Molecular Heparin Market
9.2.1. U.S. Low Molecular Heparin Market
9.2.1.1. Product breakdown estimates & forecasts, 2019-2029
9.2.1.2. Application breakdown estimates & forecasts, 2019-2029
9.2.1.3. End-User breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Low Molecular Heparin Market
9.3. Europe Low Molecular Heparin Market Snapshot
9.3.1. U.K. Low Molecular Heparin Market
9.3.2. Germany Low Molecular Heparin Market
9.3.3. France Low Molecular Heparin Market
9.3.4. Spain Low Molecular Heparin Market
9.3.5. Italy Low Molecular Heparin Market
9.3.6. Rest of Europe Low Molecular Heparin Market
9.4. Asia-Pacific Low Molecular Heparin Market Snapshot
9.4.1. China Low Molecular Heparin Market
9.4.2. India Low Molecular Heparin Market
9.4.3. Japan Low Molecular Heparin Market
9.4.4. Australia Low Molecular Heparin Market
9.4.5. South Korea Low Molecular Heparin Market
9.4.6. Rest of Asia Pacific Low Molecular Heparin Market
9.5. Latin America Low Molecular Heparin Market Snapshot
9.5.1. Brazil Low Molecular Heparin Market
9.5.2. Mexico Low Molecular Heparin Market
9.6. Rest of The World Low Molecular Heparin Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Pfizer, Inc.,
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. LEO Pharma A/S, Sanofi S.A.,
10.2.3. Teva Pharmaceutical Industries Ltd.,
10.2.4. Amphastar Pharmaceuticals Inc.,
10.2.5. Abbott Laboratories,
10.2.6. Aspen Pharmacare Holdings,
10.2.7. Laboratorios Farmaceuticos ROVI SA,
10.2.8. Changzhou Qianhong Biopharma,
10.2.9. Intrapharm Laboratories
10.2.10. Baxter International Inc.,
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption